skip to content

Bray, Frederick Thomas

CPSO#: 65372

MEMBER STATUS
Suspended as of 19 Jun 2019
CPSO REGISTRATION CLASS
Independent Practice as of 19 Jun 2019
Flag: Indicates a concern or additional information

Summary

Former Name: No Former Name

Gender: Male

Languages Spoken: English

Education:McGill University, 1989

Practice Information

Primary Location of Practice
Practice Address Not Available

Professional Corporation Information


Corporation Name: Dr. Frederick T. Bray Medicine Professional Corporation
Certificate of Authorization Status: Issued Date:  Jan 28 2004

Shareholders:
Dr. F. Bray ( CPSO# 65372 )

Business Address:
102 - 1637 Woodroffe Avenue
Ottawa ON  K2G 1W2
Phone Number: (613) 739-7753

Business Address:
Suite 207
267 O'Connor Street
Ottawa ON  K2P 1V3
Phone Number: (613) 567-8000

Specialties

Specialty Issued On Type
Internal Medicine Effective: 30 Jun 1993 RCPSC Specialist
Gastroenterology Effective: 26 Sep 2000 RCPSC Specialist

Postgraduate Training

Please note: This information may not be a complete record of postgraduate training.



University of Ottawa, 01 Jul 1993 to 30 Jun 1994
Resident 5 - Gastroenterology

Registration History

Action Issue Date
First certificate of registration issued: Postgraduate Education Certificate Effective: 01 Jul 1992
Transfer of class of registration to: Independent Practice Certificate Effective: 22 Feb 1994
Transfer of class of certificate to: Restricted certificate Effective: 21 Nov 2017
Terms and conditions imposed on certificate Effective: 21 Nov 2017
Transfer of class of registration to: Independent Practice Certificate Effective: 19 Jun 2019
Suspension of registration imposed: Discipline Committee Effective: 19 Jun 2019

Practice Restrictions Flag: indicates a concern or additional information

Registration Status: Suspended     Effective From: 19 Jun 2019


Imposed By Effective Date Expiry Date Status
Discipline Committee Effective: 19 Jun 2019 Active

Previous Hearings Flag: indicates a concern or additional information

Committee: Discipline
Decision Date: 18 Jun 2019
Summary:

On June 18, 2019, the Discipline Committee found that Dr. Frederick Thomas Bray committed 
 an act of professional misconduct in that: he has engaged in an act or omission relevant to the 
 practice of medicine that, having regard to all the circumstances, would reasonably be regarded 
 by members as disgraceful, dishonourable or unprofessional, and has failed to maintain the 
 standard of practice of the profession. 

 Dr. Bray received his medical degree at the McGill University in 1989. He received his 
 certificate of registration authorizing independent practice in Ontario in 1992. Dr. Bray received 
 his specialist qualification in internal medicine in 1993 and in gastroenterology in 2000. 

 At the relevant times, Dr. Bray was the sole physician and the Medical Director of an Out-of-
 Hospital Premises (“OHP”), operating as “Frederick T. Bray Professional Medicine Corporation” 
 in Ottawa, Ontario, providing gastroenterology services.   

Overview of the Case  

The Out-of-Hospital Premises Inspection Program, “OHPIP”, is administered by the College and 
applies to all premises outside a hospital (“OHP premises”) that perform procedures involving 
the use of anesthesia or sedation as defined in O.Reg. 114/94, made under the Medicine Act, 
 1991, (“the Regulation”). Part XI of the Regulation sets out the definition of “procedure” for the 
 purposes of the OHPIP. The OHP program is based on trust and relies on self-reporting from 
 Medical Directors and physicians. 

 Mandatory standards for OHP premises are set out in Program Standards (“the Standards”), 
 authorized under the Regulation. Pursuant to Standard 2.2, the Medical Director of an OHP is 
 responsible for the duties outlined in the Standards. In order to ensure patient safety and quality 
 of care, strict adherence is required to the detailed requirements set out in the Standards. 

 As set out Standard 3.2, “Anesthesia”, medications producing “deep sedation”, including 
 propofol, “must be administered by a physician qualified to provide deep sedation”. This point is 
 further clarified in Standard 5.3 that states that general anesthesia can only be administered by an 
 anesthesiologist. 

 By letter dated May 17, 2016, sent to all Medical Directors of OHPs, including Dr. Bray, Dr. 
 Steven Bodley, then-chair of the Premises Inspection Committee (“PIC”), reminded Medical 
 Directors that OHP Standard 3.2 required that only a qualified anesthesiologist is permitted to 
administer propofol.  

Disgraceful, Dishonourable or Unprofessional Conduct 

 In contravention of Program Standards and his duties as Medical Director, Dr. Bray administered 
 propofol to patients, in the absence of an anesthesiologist or any other physician qualified to 
 administer propofol in accordance with the Standards.     

On July 19, 2017, the OHPIP conducted an inspection-assessment of Dr. Bray’s OHP. The 
 inspection–assessment included a review of the premises’ controlled substances storage and 
 included review of the care provided by the premises to sedated patients. Dr. Bray did not advise 
                                                                                                                                    Disposition 

                                                                                                                                    On June 1


the assessors that he was using propofol despite the fact that the assessors reviewed his practices 
and procedures around sedation and controlled substances. 

The College became aware of Dr. Bray’s use of propofol through an anonymous report made to 
the College on August 3, 2017. As a result of the report, the College conducted an unannounced 
visit on August 24, 2017, and verified that Dr. Bray was administering propofol to patients 
without an anesthesiologist. 

Twenty-five (25) patient charts were obtained in the College investigation. The charts were 
reviewed by an expert retained by the College, Dr. Ted Xenodemetropoulos, a gastroenterologist. 
As set out in Dr. Xenodemetropoulos’ report, Dr. Bray administered propofol to eleven (11) 
patients in contravention of Program Standards, in the absence of an anesthesiologist. 

Failure to Maintain Standard of Practice 

In respect of the eleven (11) patients to whom propofol was administered by Dr. Bray in the 
absence of an anesthesiologist, Dr. Xenodemetropoulos opined that Dr. Bray failed to maintain 
the standard of practice in his administration of intravenous propofol as additional sedation 
during procedures and displayed a moderate lack of judgment both in his role as Medical 
Director of the OHP and as most responsible physician to the patients in question.   

Dr. Xenodemetropoulos concluded that Dr. Bray’s use of propofol did not result in an increased 
risk of harm or injury in a sedation-related adverse event to the patients. 

Admission 

Dr. Bray admits the facts specified above, and admits that, based on these facts, he engaged in 
professional misconduct:  

(a)   engaged in conduct or an act or omission relevant to the practice of medicine that, having
      regard to all the circumstances, would reasonably be regarded by members as disgraceful,
      dishonourable or unprofessional; and

(b)   he has failed to maintain the standard of practice of the profession.


        8, 2019, the Committee ordered that: 

   - The Registrar suspend Dr. Bray’s certificate of registration for a period of 4 months.
   - Dr. Bray attend before the panel to be reprimanded.
   - Dr. Bray pay costs to the College in the amount of $6000.00


Decision: Download Full Decision (PDF)
Hearing Date(s): June 18, 2019 half day start time 1:00 p.m.